Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on...
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Learn about synthetic lethality and approved drugs that use this approach to treat cancer.
Dr. Alan D’Andrea spoke about a new grant looking for fresh perspectives in Fanconi anemia-related cancer research.
The closing plenary of the AACR Annual Meeting 2024 recapped basic science, prevention, clinical advances, and more.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
The editors of AACR's journals highlight studies from May, including machine learning, savings from quitting smoking, and more.
Researchers at the AACR Annual Meeting 2024 examined new treatment options for brain tumors.
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.
The latest installment of this quarterly series highlights innovative research approaches reported at the AACR Annual Meeting 2024.
Insights from the AACR Cancer Disparities Progress Report 2024.